toxylact: a06ab58 sodium picosulfate combinations
The first professional lActological database in the word
Sodium picosulfate combinations (ATC A06AB58) are stimulant contact laxatives, most often combined with magnesium oxide and citric acid, used primarily for bowel cleansing before colonoscopy and, less commonly, for short‑term treatment of constipation.medpedia.framar+3
Pharmacological class and composition
Sodium picosulfate belongs to the group of
contact laxatives
within drugs for constipation (ATC A06AB).genome+2
Combinations in A06AB58 typically contain sodium picosulfate
together with
magnesium oxide and anhydrous or hydrated citric acid, which
react in the gut
to form magnesium citrate, enhancing osmotic fluid retention
in the colon.drugs.ncats+2
The combined stimulant (sodium picosulfate) and osmotic
(magnesium citrate)
actions produce a powerful purgative effect suitable for
full bowel cleansing.drugbank+2
Indications and clinical use
Medicinal products in class A06AB58 are
indicated for bowel
cleansing before colonoscopy or other colon imaging
procedures.mayoclinic+2
They may also be used off‑label or in some formulations for
short‑term relief
of constipation where strong laxation is desired, although
routine use for
simple constipation is generally discouraged.breastfeedingnetwork+2
In many colonoscopy prep protocols, sodium picosulfate
combinations are given
as sachets dissolved in water, with additional clear fluids
to optimize
cleansing efficacy.mycolonoscopy+2
Mechanism of action
Sodium picosulfate is a prodrug that is
converted by colonic
bacteria into an active metabolite
(bis-(p-hydroxyphenyl)-pyridyl-2-methane),
which directly stimulates colonic mucosa and peristalsis.medpedia.framar+2
The magnesium oxide and citric acid components react to form
magnesium citrate,
an osmotic laxative that retains water in the intestinal
lumen, increasing
stool volume and liquidity.medlineplus+1
Together, these mechanisms cause accelerated transit and
watery diarrhea,
producing thorough evacuation of colonic contents.drugbank+3
Posology and administration
Sodium picosulfate combinations are
administered orally as
sachets of powder that are dissolved in a specified volume
of water immediately
before use.mayoclinic+2
Typical colonoscopy regimens involve two doses separated by
several hours
(e.g., one dose the evening before and one dose on the day
of the procedure),
each followed by large volumes of clear fluids.mycolonoscopy+2
In all cases, dosing must follow the specific product
characteristics and local
colonoscopy protocols, and concomitant oral medications
should be separated by
at least one hour to reduce the risk of impaired absorption.medlineplus+1
Contraindications and cautions
Sodium picosulfate combinations are
contraindicated in intestinal
obstruction (ileus), acute surgical abdomen, severe
inflammatory bowel disease
(including severe colitis and active Crohn’s disease), and
suspected
appendicitis.medpedia.framar+2
They should not be used in patients with clinically
significant dehydration or
severe renal impairment due to the risk of electrolyte
disturbances and fluid
shifts.mayoclinic+1
Caution is required in elderly patients, those with cardiac
disease, and
patients on medications that predispose to electrolyte
imbalance, as rapid
fluid and electrolyte shifts during purgation may
precipitate clinical
deterioration.medlineplus+2
Adverse effects and toxicity
The most frequent adverse effects are
abdominal cramps, bloating,
nausea, and transient watery diarrhea, which are part of the
expected
pharmacodynamic effect.medpedia.framar+2
Allergic reactions and more severe colitis‑like symptoms are
uncommon but have
been reported, necessitating discontinuation and clinical
assessment if severe
pain or bleeding occurs.mayoclinic+2
Overdose or improper use can lead to severe diarrhea with
dehydration and
electrolyte disturbances (hypokalemia, hyponatremia), which
may present with
dizziness, weakness, arrhythmias or seizures in susceptible
patients.breastfeedingnetwork+3
Drug interactions
Concomitant use with diuretics or systemic
glucocorticoids
increases the risk of electrolyte imbalance during intensive
bowel cleansing.medlineplus+2
Use with other stimulant laxatives or large doses of osmotic
agents can
potentiate gastrointestinal adverse effects and dehydration.breastfeedingnetwork+1
Because of rapid intestinal transit and fluid shifts, oral
medications taken
close to the time of bowel prep (within about one hour) may
have reduced
absorption; product information usually advises separating
other drugs from the
prep.medpedia.framar+2
Use in pregnancy
Data on sodium picosulfate combinations in
pregnancy are limited,
and colonoscopy itself is rarely indicated during pregnancy;
use should
therefore be restricted to situations where the expected
benefit clearly
outweighs potential risks.mims+2
For chronic functional constipation in pregnancy, expert
guidance favors bulk‑forming
agents and osmotic laxatives over stimulant preparations;
sodium picosulfate is
generally avoided except when other options fail and
short‑term use is
necessary.pubmed.ncbi.nlm.nih
If bowel cleansing is absolutely required during pregnancy,
individualized
risk–benefit assessment and specialist consultation are
essential before using
sodium picosulfate combinations.mims+2
Use in lactation (toxico‑lactological focus)
Sodium picosulfate itself is minimally
absorbed from the
gastrointestinal tract, and its active metabolite is formed
locally in the
colon, resulting in negligible systemic exposure and very
low passage into breast
milk.ncbi.nlm.nih+2
The Drugs and Lactation Database (LactMed) reports that
sodium picosulfate can
be taken during breastfeeding without the need for special
precautions, based
on postpartum use with no adverse effects observed in
breastfed infants.ncbi.nlm.nih
Specialist resources indicate that any standard laxative,
including stimulant
agents such as sodium picosulfate, can be used in
breastfeeding when clinically
necessary, though routine long‑term use of stimulant
laxatives is discouraged
and bulk or osmotic agents are preferred for chronic
constipation.sps+1
In the context of A06AB58 colonoscopy
preparations, the transient
high‑dose exposure occurs as a single or short sequence of
doses, and
clinically significant effects on the breastfed infant are
unlikely due to poor
maternal systemic absorption and rapid elimination.ncbi.nlm.nih+2
Because the purgative regimen can cause maternal diarrhea,
dehydration and
fatigue, breastfeeding mothers should be advised to maintain
adequate fluid
intake and monitor infant feeding behavior, but interruption
of breastfeeding
is generally not required.sps+2
In lactation‑focused toxicological classification, sodium
picosulfate
combinations can be considered compatible with breastfeeding
for short‑term
use, with preference for alternative laxatives for routine
management of
constipation and with caution in premature or medically
fragile infants where
any maternal medicine exposure is assessed more
conservatively.mayoclinic+3
Special populations and practical considerations
In patients with porphyria, some references
classify sodium
picosulfate/magnesium oxide/citric acid preparations as
acceptable or safe, but
prescribers should consult dedicated porphyria drug safety
resources when
needed.drugsporphyria
Pediatric use for colonoscopy preparation must follow
age‑appropriate
protocols, as excessive fluid or electrolyte loss can be
more clinically
significant in children.mayoclinic+1
For all patients, clear instructions regarding diet (clear
liquids only,
avoidance of certain foods and colors) and timing of doses
are crucial to
ensure effective bowel cleansing and minimize toxicity.clevelandclinic+3



